Found: 24
Select item for more details and to access through your institution.
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2109, doi. 10.1093/neuonc/noad194
- Publication type:
- Article
Correction to: Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells.
- Published in:
- 2023
- Publication type:
- Correction Notice
Correction to: HGG-16. COMPARATIVE ANALYSIS OF AUTOPHAGY IN DRUG RESPONSES AND AGGRESSIVE BEHAVIOR OF ADULT VERSUS PEDIATRIC GLIOMA CELL LINES.
- Published in:
- 2023
- Publication type:
- Correction Notice
Correction to: Mapping pediatric brain tumors to their origins in the developing cerebellum.
- Published in:
- 2023
- Publication type:
- Correction Notice
The INDIGO trial: Precision medicine finally comes to glioma.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Prognostic value of integrative genomic approaches for IDH-mutant gliomas.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Reply to "Targeting cholesterol homeostasis through inhibiting: An Achilles' heel for glioblastoma?".
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2103, doi. 10.1093/neuonc/noad146
- By:
- Publication type:
- Article
Targeting cholesterol homeostasis through inhibiting SREBP-2: An Achilles' heel for glioblastoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2100, doi. 10.1093/neuonc/noad145
- By:
- Publication type:
- Article
"LOGGIC" of RNA-sequencing in enhancing diagnoses of pediatric low-grade gliomas.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2098, doi. 10.1093/neuonc/noad142
- By:
- Publication type:
- Article
Chimeric antigen receptors in the brain: Can we tackle glioblastoma with engineered NK cells?
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2072, doi. 10.1093/neuonc/noad131
- By:
- Publication type:
- Article
Watching the clock in glioblastoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 1932, doi. 10.1093/neuonc/noad107
- By:
- Publication type:
- Article
Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 1920, doi. 10.1093/neuonc/noad125
- By:
- Publication type:
- Article
Nonstructural maintenance of chromatin condensin I complex subunit G promotes the progression of glioblastoma by facilitating Poly (ADP-ribose) polymerase 1-mediated E2F1 transactivation.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2015, doi. 10.1093/neuonc/noad111
- By:
- Publication type:
- Article
What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 1915, doi. 10.1093/neuonc/noad113
- By:
- Publication type:
- Article
Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2001, doi. 10.1093/neuonc/noad108
- By:
- Publication type:
- Article
Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant glioma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2028, doi. 10.1093/neuonc/noad126
- By:
- Publication type:
- Article
PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2074, doi. 10.1093/neuonc/noad105
- By:
- Publication type:
- Article
M2 isoform of pyruvate kinase rewires glucose metabolism during radiation therapy to promote an antioxidant response and glioblastoma radioresistance.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 1989, doi. 10.1093/neuonc/noad103
- By:
- Publication type:
- Article
EPIC-0307-mediated selective disruption of PRADX–EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 1976, doi. 10.1093/neuonc/noad102
- By:
- Publication type:
- Article
Sialic acid metabolism orchestrates transcellular connectivity and signaling in glioblastoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 1963, doi. 10.1093/neuonc/noad101
- By:
- Publication type:
- Article
Upstream open reading frame-encoded MP31 disrupts the mitochondrial quality control process and inhibits tumorigenesis in glioblastoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 1947, doi. 10.1093/neuonc/noad099
- By:
- Publication type:
- Article
Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2044, doi. 10.1093/neuonc/noad097
- By:
- Publication type:
- Article
LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2087, doi. 10.1093/neuonc/noad078
- By:
- Publication type:
- Article
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2058, doi. 10.1093/neuonc/noad087
- By:
- Publication type:
- Article